General
Preferred name
ROPIDOXURIDINE
Synonyms
IPdR ()
IPD-R ()
NSC-726188 ()
Ropidoxuridina ()
P&D ID
PD077525
CAS
93265-81-7
Tags
available
prodrug
drug candidate
Drug Status
investigational
Max Phase
2.0
Drug indication
Lymphoma
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Ropidoxuridine (IPdR) is a novel orally available, halogenated thymidine analog and is a potential radiosensitizer for use in human tumors.
PRICE
179
DESCRIPTION
Ropidoxuridine is a novel, orally available 5-substituted 2-pyrimidinone-2'-deoxyribonucleoside analogue and prodrug of 5-iododeoxyuridine (IUdR). It has radiosensitizing activity. It is efficiently converted to idoxuridine (IUdR) by a hepatic aldehyde oxidase. It is incorporated into DNA during replication, thereby sensitizing cells to ionizing radiation by increasing DNA strand breaks. It is associated with a lower toxicity profile and improved anti-tumor activity. It has dose responsive and synergistic effects. It has also shown reduced toxicity, with better tissue incorporation and improved anti-tumor activity. It maybe used to treat colorectal, gastric, and pancreatic cancer, and other solid tumors.
(BOC Sciences Bioactive Compounds)
DESCRIPTION
Ropidoxuridine (IPdR) is a novel, orally available halogenated thymidine analogue that holds promise as a sensitizer for human tumors.Ropidoxuridine is an orally available and bioavailable IUdR (5-iodo-2'-deoxyuridine) prodrug.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
BOC Sciences Bioactive Compounds
Cayman Chemical Bioactives
ChEMBL Drugs
DrugBank
MedChem Express Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
18
Molecular Weight
337.98
Hydrogen Bond Acceptors
6
Hydrogen Bond Donors
2
Rotatable Bonds
2
Ring Count
2
Aromatic Ring Count
1
cLogP
-0.51
TPSA
84.58
Fraction CSP3
0.56
Chiral centers
3.0
Largest ring
6.0
QED
0.71
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
HSV
Pathway
Anti-infection
Solubility
10 mM in DMSO
Source data

